Search Results 111-120 of 25588 for stem cell
Stem cells show potential to safely slow progression of organ rejection in some lung transplant recipients, according to early Mayo Clinic research.
Mayo Clinic researchers are studying how mesenchymal stem cells might treat the effects of intracerebral hemorrhage. Preclinical work demonstrated the ...
The overall goal of this study is to develop mesenchymal stem cell therapy for treatment of acute spontaneous hemorrhagic stroke. Participation eligibility.
The Epigenetic Etiology of Human Disease Laboratory at Mayo Clinic is analyzing DNA methylation and histone modifications over the stem cell genome.
Pediatric onset of Crohn's disease is associated with more-aggressive perianal fistula development. New therapy derives stem cells from patients' fat cells ...
To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS). Participation ...
The purpose of this study is to provide up to three intrathecal injections of NurOwn® (MSC-NTF cells, autologous Mesenchymal Stem Cells [MSC] Secreting ...
The study seeks to answer whether stem cells can slow the debilitating effects of ALS, and if so, why stem cell therapy works for some but not others. "We are ...
More than 90 percent of people older than 50 experience intervertebral disk (IVD) degeneration. In animal studies, stem cell transplantation to the disk has ...
Stem cells have the capability to develop into bone, cartilage, fat, skin or blood vessels, and are thought to be involved in the healing process. Using your ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.